| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2008 | CA2675788A1 Oxaliplatin pharmaceutical composition with alcoholic sugar-based buffer |
| 07/31/2008 | CA2675632A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | CA2675621A1 3 - cinnolinecarboxamide derivatives and their use for treating cancer |
| 07/31/2008 | CA2675538A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | CA2675142A1 Fused aromatic difluoromethanephosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 07/31/2008 | CA2674921A1 Benzoquinazoline derivatives |
| 07/31/2008 | CA2674875A1 Purine derivatives |
| 07/31/2008 | CA2674717A1 Use of d-ribose to treat cardiac arrhythmias |
| 07/31/2008 | CA2674636A1 Treatment of faecal incontinence |
| 07/31/2008 | CA2674568A1 New unsaturated fatty amino-acid derivatives and use thereof in dermal cosmetology |
| 07/31/2008 | CA2673851A1 Polyelectrolyte precipitation and purification of proteins |
| 07/31/2008 | CA2673164A1 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 07/31/2008 | CA2672971A1 Stabilized sulforaphane |
| 07/31/2008 | CA2669406A1 Polymer-linked-bisphosphonate inhalant formulations and methods for using the same |
| 07/31/2008 | CA2642273A1 Bifunctional histone deacetylase inhibitors |
| 07/31/2008 | CA2619193A1 Polyphenol-based composition, and methods and systems for its preparation |
| 07/30/2008 | EP1950563A2 Method for screening for a substance for promoting regeneration of macrophages |
| 07/30/2008 | EP1950297A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 07/30/2008 | EP1950296A2 Oligodeoxynucleotide and its use to induce an immune response |
| 07/30/2008 | EP1950227A1 HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF |
| 07/30/2008 | EP1950226A2 Receptors for human interleukin-12 |
| 07/30/2008 | EP1950219A1 Novel dihydropseudoerythromycin derivatives |
| 07/30/2008 | EP1950218A1 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis |
| 07/30/2008 | EP1950217A1 Organometallic compounds for the treatment of cancer |
| 07/30/2008 | EP1950212A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 07/30/2008 | EP1950211A1 Process for production of cinnamamide derivative |
| 07/30/2008 | EP1950209A1 Agent for treatment of circulatory failure |
| 07/30/2008 | EP1950206A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/30/2008 | EP1950205A1 Method for stabilization of isoxazole compound |
| 07/30/2008 | EP1950204A1 Amorphous form of valsartan |
| 07/30/2008 | EP1950203A1 Substituted pyrazoline compounds with ACAT, their preparation and use as medicaments |
| 07/30/2008 | EP1950202A1 Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949937A1 Lipoxin analogs as novel inhibitors of restenosis |
| 07/30/2008 | EP1949912A2 Treatment of chronic lymphcytic leukemia (CLL) using chimeric anti-CD20 antibody |
| 07/30/2008 | EP1949911A2 Treatment of chronique lymphocytic leukemia using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949910A1 Treatment of chronic lymphocytic leukemia (CLL) using chimeric anti-CD20 antibody. |
| 07/30/2008 | EP1949909A1 Use of Botulinum Toxin Therapy for Treatment of Urge Type Dysfunction |
| 07/30/2008 | EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 07/30/2008 | EP1949903A2 Compounds for the treatment of auricular fibrillation |
| 07/30/2008 | EP1949902A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949900A2 Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof |
| 07/30/2008 | EP1949899A1 Metal salophen complexes use in prevention and treatment of cancer |
| 07/30/2008 | EP1949898A1 Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| 07/30/2008 | EP1949897A1 Inflammation mediated vascular lesions |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1949895A1 Iontophoresis preparation |
| 07/30/2008 | EP1949894A2 Enhancement of vanadium-containing phosphatase inhibitors by polyols |
| 07/30/2008 | EP1949893A2 Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors |
| 07/30/2008 | EP1949892A1 Aerosol for inhalation comprising a tiotropium salt |
| 07/30/2008 | EP1949891A1 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
| 07/30/2008 | EP1949890A2 Implantable gel compositions and method of manufacture |
| 07/30/2008 | EP1949888A1 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 07/30/2008 | EP1949801A1 Nutritious and regenerative drink |
| 07/30/2008 | EP1948810A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 07/30/2008 | EP1948675A2 Methods and compositions for the treatment of marfan syndrome and associated disorders |
| 07/30/2008 | EP1948674A1 Modified sirna molecules and uses thereof |
| 07/30/2008 | EP1948667A2 Thiazolo[4,5-c]pyridine derivatives as mglu5 receptor antagonists |
| 07/30/2008 | EP1948666A1 Hiv integrase inhibitors |
| 07/30/2008 | EP1948665A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 07/30/2008 | EP1948664A2 Pyrrolotriazine kinase inhibitors |
| 07/30/2008 | EP1948663A2 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 07/30/2008 | EP1948662A2 Tricyclic compounds useful as oxytocin receptor agonists |
| 07/30/2008 | EP1948661A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/30/2008 | EP1948660A1 Tetracyclic indole derivatives as antiviral agents |
| 07/30/2008 | EP1948659A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948658A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948657A1 Azaindazoles useful as inhibitors of kinases |
| 07/30/2008 | EP1948656A2 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948654A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 07/30/2008 | EP1948653A1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/30/2008 | EP1948652A1 Glucokinase activators |
| 07/30/2008 | EP1948651A1 Thiazole analogues and uses thereof |
| 07/30/2008 | EP1948650A1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders |
| 07/30/2008 | EP1948648A2 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives |
| 07/30/2008 | EP1948647A1 Pyrimidinyl-thiophene kinase modulators |
| 07/30/2008 | EP1948646A2 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 07/30/2008 | EP1948645A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948644A1 Tricyclo substituted amides |
| 07/30/2008 | EP1948642A1 4-heteroarymethyl substituted phthalazinone derivatives |
| 07/30/2008 | EP1948641A1 An improved process for preparation of irbesartan |
| 07/30/2008 | EP1948638A1 Compounds for the treatment of inflammatory disorders |
| 07/30/2008 | EP1948636A2 Compounds and compositions as lxr modulators |
| 07/30/2008 | EP1948635A1 Benzimidazole derivatives as gyrase inhibitors |
| 07/30/2008 | EP1948632A1 Flavone sulfates and their use as antioxidants |
| 07/30/2008 | EP1948630A2 Novel compounds |
| 07/30/2008 | EP1948628A1 Quetiapine hemifumarate purification by crystallization |
| 07/30/2008 | EP1948627A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 07/30/2008 | EP1948624A2 Process for the preparation of benzo[e][1,2,4]triazepin-2-one derivatives |
| 07/30/2008 | EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/30/2008 | EP1948622A1 Tricyclo substituted amides as glucokinase modulators |
| 07/30/2008 | EP1948621A1 Hiv integrase inhibitors |
| 07/30/2008 | EP1948620A2 Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist |
| 07/30/2008 | EP1948619A2 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
| 07/30/2008 | EP1948618A1 Crystalline rosuvastatin calcium |
| 07/30/2008 | EP1948617A2 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/30/2008 | EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |